Multiple Sclerosis
Conference Coverage
Genetic Variations May Affect Vitamin D Level and MS Relapse Rate
BALTIMORE—A genetic scoring system for identifying individuals at high risk for low vitamin D levels also detects patients with multiple sclerosis...
Conference Coverage
Neuronal Protein Could Be a Blood Biomarker of MS
LONDON—Higher levels of a neuronal protein were found in the blood of patients with relapsing-remitting multiple sclerosis (RRMS) than in healthy...
Conference Coverage
Choosing Wisely Initiative Helps Physicians Provide Appropriate Care
HILTON HEAD, SC—Physicians sometimes order unnecessary medical tests and procedures for their patients, which results in wasteful spending and...
Conference Coverage
Genetic risk score for low vitamin D may affect MS relapse rate
BALTIMORE
Conference Coverage
Efficacy of Cladribine Tablets Continues After Conversion to MS
LONDON—Significant treatment effect versus placebo of cladribine tablets given to patients with clinically isolated syndrome during the initial...
Audio
Paulo Fontoura, MD, PhD
Dr. Fontoura examines the effect that ocrelizumab has on the composite end point of no evidence of disease progression in MS.
Conference Coverage
Evaluation of Cortical Lesions Could Improve Diagnosis of MS
LONDON—Evaluation of cortical lesions improves the specificity of the diagnostic criteria for multiple sclerosis (MS), according to research...
Conference Coverage
Smoking, vitamin D deficiency linked to early MS disability
LONDON – Severe vitamin D deficiency and current smoking predicted accumulated disability in patients with clinically isolated syndrome, which can...
Conference Coverage
Fluoxetine fails to slow progressive multiple sclerosis
LONDON – Contrary to expectation of a neuroprotective benefit, fluoxetine does not slow down the progressive phase of multiple sclerosis,...
Conference Coverage
Neuronal protein could be multiple sclerosis blood biomarker
LONDON
Conference Coverage
Retinal Measurements Predict 10-Year Disability in MS
LONDON—As has been previously shown with brain atrophy and lesion volume, retinal measures can have predictive value for medium-term disability in...